P31 A novel disease endotype in SLE characterized by B cell hyperactivity, Sm/RNP reactivity and higher disease activity

Benzer Materyaller

• 301 The Lupus Risk Index (LRI) as a biomarker in patients with lupus nephritis
  Yazar:: Cynthia Aranow, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-12-01)
• Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
  Yazar:: Emiliano Marasco, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-12-01)
• Mechanisms of autoantibody production in systemic lupus erythematosus
  Yazar:: Shuhong eHan, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-05-01)
• Phenotypic and functional characteristics of murine CD11c+ B cells which is suppressed by metformin
  Yazar:: Ivan Ramirez De Oleo, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-09-01)
• Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
  Yazar:: Pier Luigi Meroni, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-02-01)